Dana-Farber Cancer Institute Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Dana-Farber Cancer Institute and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10000 Dana-Farber Cancer Institute employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Dana-Farber Cancer Institute has purchased the following applications: MicroStrategy ONE Analytics for Analytics and BI in 2012, New Relic APM for Application Performance Management in 2021, Zoom for Audio Video and Web Conferencing in 2021 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Dana-Farber Cancer Institute is running and its propensity to invest more and deepen its relationship with MicroStrategy , New Relic , Zoom Video Communications or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Dana-Farber Cancer Institute revenues, which have grown to $2.67 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Dana-Farber Cancer Institute intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.